Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein. - Wikidata - thesis-toulmin - TriplyDB

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

http://www.wikidata.org/entity/Q37115285

about

HIV-1 Vpu neutralizes the antiviral factor Tetherin/BST-2 by binding it and directing its beta-TrCP2-dependent degradation The great escape: viral strategies to counter BST-2/tetherin The formation of cysteine-linked dimers of BST-2/tetherin is important for inhibition of HIV-1 virus release but not for sensitivity to Vpu BST2/Tetherin enhances entry of human cytomegalovirus Species-specific activity of SIV Nef and HIV-1 Vpu in overcoming restriction by tetherin/BST2 Cellular and viral factors regulating Merkel cell polyomavirus replication Infectious Lassa virus, but not filoviruses, is restricted by BST-2/tetherin Interferon-induced cell membrane proteins, IFITM3 and tetherin, inhibit vesicular stomatitis virus infection via distinct mechanisms Structural basis of HIV-1 tethering to membranes by the BST-2/tetherin ectodomain How SAMHD1 changes our view of viral restriction HIV-1 Vpu targets cell surface markers CD4 and BST-2 through distinct mechanisms BST-2/tetherin: a new component of the innate immune response to enveloped viruses Antiviral inhibition of enveloped virus release by tetherin/BST-2: action and counteraction Vpu directs the degradation of the human immunodeficiency virus restriction factor BST-2/Tetherin via a {beta}TrCP-dependent mechanism HIV-1 accessory protein Vpu internalizes cell-surface BST-2/tetherin through transmembrane interactions leading to lysosomes Direct restriction of virus release and incorporation of the interferon-induced protein BST-2 into HIV-1 particles Three-Dimensional Structural Characterization of HIV-1 Tethered to Human Cells.Characterization of Determinants Important for Hepatitis C Virus p7 Function in Morphogenesis by Using trans-Complementation Marburg Virus Evades Interferon Responses by a Mechanism Distinct from Ebola Virus Structural and functional studies on the extracellular domain of BST2/tetherin in reduced and oxidized conformations Structural insight into the mechanisms of enveloped virus tethering by tetherin Structural and Biophysical Analysis of BST-2/Tetherin Ectodomains Reveals an Evolutionary Conserved Design to Inhibit Virus Release In Silico Derived Small Molecules Bind the Filovirus VP35 Protein and Inhibit Its Polymerase Cofactor Activity Immunoelectron microscopic evidence for Tetherin/BST2 as the physical bridge between HIV-1 virions and the plasma membrane Bone marrow stromal cell antigen 2 (BST-2) restricts mouse mammary tumor virus (MMTV) replication in vivo Expression of HIV-1 Vpu leads to loss of the viral restriction factor CD317/Tetherin from lipid rafts and its enhanced lysosomal degradation Mechanism of HIV-1 virion entrapment by tetherin Interferon-induced tetherin restricts vesicular stomatitis virus release in neurons HSV-2 glycoprotein gD targets the CC domain of tetherin and promotes tetherin degradation via lysosomal pathway Counteraction of tetherin antiviral activity by two closely related SIVs differing by the presence of a Vpu gene Vpu and BST2: Still Not There Yet?Differential sensitivities of tetherin isoforms to counteraction by primate lentiviruses.Tetherin Sensitivity of Influenza A Viruses Is Strain Specific: Role of Hemagglutinin and Neuraminidase.Tetherin-driven adaptation of Vpu and Nef function and the evolution of pandemic and nonpandemic HIV-1 strains.Modulation of HIV-1-host interaction: role of the Vpu accessory protein Maturation and vesicle-mediated egress of primate gammaherpesvirus rhesus monkey rhadinovirus require inner tegument protein ORF52.Tetherin restricts direct cell-to-cell infection of HIV-1.Ultra structural characterisation of tetherin - a protein capable of preventing viral release from the plasma membrane Identification and functional analysis of three isoforms of bovine BST-2 Mutation of a single residue renders human tetherin resistant to HIV-1 Vpu-mediated depletion.

P2860

19cdc0a68d53bb979b62ea83b0646ebd279eb524

P248

Q21089617-33401329-78A0-4F52-BDD0-77DECBD08A08 Q21090506-D22AE306-28C9-4376-9C9F-8587213823F5 Q21245050-0FB8D4DA-01C1-4AAB-8350-3E1803124B57 Q21559401-FDA05529-BCDD-4A7D-AAED-B263397955DE Q21559418-6E776ED0-FB83-4FAF-A30B-1B1729571286 Q21560943-32227996-8A97-4DF8-B5EA-8BC5427058CE Q24294470-696FD4F1-5E99-4DF2-8EA7-7BCDE065E734 Q24302747-EECB6C14-B7A4-45A9-819F-92A7052E56A8 Q24306855-A0D568B3-F0AA-4E2B-B8D8-53B7130C9967 Q24605899-ED35CDC4-1C70-4A09-9792-9AFF8B382C99 Q24619066-D993E68E-8751-4C1F-B4D9-CD67FF46ED45 Q24630382-26C38AA2-ECDF-420F-AD99-434F70068566 Q24635271-1776E98B-6C6A-4B8F-A8A6-0DB5C62FF17F Q24644811-6C851DBD-91F1-4C70-862F-A30A0C78722C Q24646984-9422C271-B3F7-444D-AF0B-21A01C0F4727 Q27316022-DAF456BE-8D61-4750-8D25-7958BBEEEF6C Q27321247-0CF991D8-F0A3-4773-B58D-B256B5A57439 Q27490303-8039C0C0-EBA5-4AA3-9ADD-D86CEC64A6BB Q27490714-27345810-9431-4702-8096-BF0C85FDBB19 Q27664759-CBA48F3C-1F8D-4197-A689-47E2924BACA9 Q27664987-D8D0E5E1-339A-4DCF-ACF1-86014161B2E3 Q27665937-BFD29606-0E8B-4FDF-9413-E9CCFBA738F6 Q27681581-ED3FE19A-1398-493A-88FF-A8F059C59AE2 Q28472771-087D3D8E-79D8-4F96-B890-DB76373C64E4 Q28510187-45294649-D9BA-491E-A8C6-A77EEFBBF9F7 Q28533773-03BF1280-DBF3-4524-94FF-19671EDD7979 Q28534707-8520C043-BD68-42DB-8264-82D997AF8479 Q28585561-89FB04A8-441A-43FA-84BB-616D3BCE6F01 Q28595739-A75B57B1-CDC6-4C7D-87B1-8F8D176F471D Q28730542-CE353BB8-77F2-49C9-809F-0B6C1E93D22C Q28730708-74830AC6-9D04-4AE8-A105-03C9F4E6B419 Q30360141-42A1D7D3-EFE8-4B2E-B13C-50CF0FAAD7B7 Q30376050-829BEB98-C77A-4D02-B794-1EA806521FC2 Q30382590-DE0573CE-2F17-46BB-A865-96BDCABB291D Q30397761-19F241DA-A638-4529-973C-0FEC16CDFFE6 Q30408375-E6D61A25-1487-41A8-8787-033B5EA47C68 Q30497822-CE647558-33A2-499A-BDAE-B0846A4A5557 Q31034125-31ED80B3-CC6F-4142-BDC5-3BAFEDC857A3 Q31086787-E3C462C7-5CE9-4678-AECA-96B3506A52EE Q33450556-113ED8EB-0A8D-433F-A45E-56A1B5F61C32

P2860

Tetherin-mediated restriction of filovirus budding is antagonized by the Ebola glycoprotein.

http://www.wikidata.org/entity/Q37115285

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 28 January 2009

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Tetherin-mediated restriction ...... zed by the Ebola glycoprotein.

@en

Tetherin-mediated restriction ...... zed by the Ebola glycoprotein.

@nl

type

label

Tetherin-mediated restriction ...... zed by the Ebola glycoprotein.

@en

Tetherin-mediated restriction ...... zed by the Ebola glycoprotein.

@nl

prefLabel

Tetherin-mediated restriction ...... zed by the Ebola glycoprotein.

@en

Tetherin-mediated restriction ...... zed by the Ebola glycoprotein.

@nl

P1433

Q37115285-00BDA656-1FAF-4292-BAD8-245467E71646

P1476

Q37115285-D71F13BD-64A1-44B7-8956-58BD34FC8FAE

P2093

Q37115285-170C8FED-6BEF-4492-8675-9CF5DD7ED502

Q37115285-220BC178-FDCF-4AEA-AC3E-F07912C6B5B8

Q37115285-99EF817E-2EF6-4B1F-9328-3183F17ADE91

P2860

Q37115285-13EEB2F5-7B49-4DE1-BB48-1D9E8F466D67

Q37115285-25B9CA13-ABD3-463B-8DE1-DDD45B557D64

Q37115285-377B2D8A-4120-4578-B6E5-251F55A5BD67

Q37115285-412B7DDB-3FE8-4E0C-A6F1-177153E28071

Q37115285-4163EF62-887D-403A-B06B-4ECC5A9555C0

Q37115285-42D4A83B-72CB-482C-8FDE-9A0DB55A0CF3

Q37115285-4921952F-F72D-4D42-A60D-DCC96575F41B

Q37115285-4A7DF06B-5162-4645-AFB9-B12A27E91833

Q37115285-4F1A001B-A4D1-4A03-9019-1182D0979468

Q37115285-51DFFFA1-5D8A-402A-8E60-E087BC9B9469

P304

Q37115285-E3361FC0-A7E0-471F-80A5-7F4844B2B981

P31

Q37115285-B16DE13C-90AC-4CCC-9C67-CAC69FDE6294

P356

Q37115285-90FE6A5B-8E04-4335-9889-69AFD8E3ED6E

P407

Q37115285-9C9AB297-73ED-40BC-8AF4-B485448ED668

P433

Q37115285-C445BC3B-5189-49B6-9F5D-0035E3D5261D

P478

Q37115285-9B4B1DEF-09AC-4814-8E6F-69D3BBED0CC9

P50

Q37115285-02033468-F846-4291-A878-ADEC4C1FABFF

P577

Q37115285-A1A6EA8B-1968-4510-BF46-B618DB9D37E4

P5875

Q37115285-42166B35-3C69-48A8-9979-C2941625ED37

P698

Q37115285-51133123-2CCC-4B11-9466-DF9C8B5E9B5A

P921

Q37115285-B73FDA7E-1692-4610-A401-E15679C8A7C2

P932

Q37115285-AD408BD9-180A-41A2-98C2-A1FA4B890298

P356

PNAS.0811014106

P1433

Proceedings of the National Academy of Sciences of the United States of America

P1476

Tetherin-mediated restriction ...... ized by the Ebola glycoprotein

@en

P2093

Caroline Agrawal-Gamse

http://www.w3.org/2001/XMLSchema#string

Joseph R Francica

http://www.w3.org/2001/XMLSchema#string

Paul Bates

http://www.w3.org/2001/XMLSchema#string

P2860

Structure of the Ebola virus glycoprotein bound to an antibody from a human survivor

A PPxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: implications for filovirus budding

Bst-2/HM1.24 is a raft-associated apical membrane protein with an unusual topology

Tetherin inhibits retrovirus release and is antagonized by HIV-1 Vpu

The interferon-induced protein BST-2 restricts HIV-1 release and is downregulated from the cell surface by the viral Vpu protein

HIV-1 Vpu promotes release and prevents endocytosis of nascent retrovirus particles from the plasma membrane.

Endoproteolytic processing of the ebola virus envelope glycoprotein: cleavage is not required for function.

Functional domains within the human immunodeficiency virus type 2 envelope protein required to enhance virus production.

Biochemical analysis of the secreted and virion glycoproteins of Ebola virus.

Ebola virus VP40 drives the formation of virus-like filamentous particles along with GP

P304

2886-2891

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1073/PNAS.0811014106

http://www.w3.org/2001/XMLSchema#string

P407

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

106

http://www.w3.org/2001/XMLSchema#string

P50

Rachel Kaletsky

P577

2009-01-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

23959388

http://www.w3.org/2001/XMLSchema#string

P698

19179289

http://www.w3.org/2001/XMLSchema#string

P921

P932

2650360

http://www.w3.org/2001/XMLSchema#string